Industry Trend Analysis
The cardiac monitoring & cardiac rhythm management market is expected to be worth $32.44billion by 2025, while growing at a CAGR of 4.12%. The market is largely driven by factors such as rising incidence of cardiovascular disorders along with technological advancements in cardiac monitoring & cardiac rhythm management devices. According to a report published by American Heart Association in 2017, around 92.1 million American adults are living with some or other type of cardiovascular disease. The estimated number of new heart attacks in U.S. is 580,000 with 210,000 incidences of recurrent attacks.Moreover, increasing geriatric population around the world also contributes substantially to the market growth as older adults are more susceptible to cardiovascular disorders such as stroke, heart failure, congenital heart disease, angina, arrhythmia and myocardial infarction. However, high cost of devices, inadequate insurance coverage and more preference for drugs is expected to slow down growth of the cardiac monitoring and rhythm management market.
Product Outlook and Trend Analysis
The electrocardiogram (ECG) devices segment held the major share of the cardiac monitoring devices market in 2016 owing to their critical benefits in detecting cardiac infarction, coronary vessel diseases, lack or abundance of certain minerals and their influence on impulse conduction and atrial fibrillation or atrial flutter. Event monitors segment is expected to grow with the fastest growth rate during the forecast period owing to their small size and light weight which makes them convenient to be carried to the patient’s site. The defibrillators segment is expected to hold the largest share of the cardiac rhythm management market during the forecast period owing to large scale adoption of defibrillators around the world along with rising incidence of sudden heart attacks (SCA).
End User Outlook and Trend Analysis
Hospitals and clinics segment accounted for the majority share of the overall market in 2016 due to the large scale adoption of cardiac monitoring & cardiac rhythm management devices in hospital settings to treat patients suffering from acute and chronic cardiovascular diseases. Ambulatory surgical centers segment is expected to witness fastest growth during the forecast period due to the advent of advanced devices which enable cost effective cardiac monitoring and management as compared to hospital based treatment.
Regional Outlook and Trend Analysis
North America held a major share of the cardiac monitoring & cardiac rhythm management market in 2016 owing to rising incidence of heart failure and arrhythmia accompanied by increasing geriatric population. Also, availability of favorable reimbursement policies related to cardiac monitoring & cardiac rhythm management devices in the region is expected to largely contribute to the robust growth of North American market. Asia-Pacific cardiac monitoring & cardiac rhythm management market is expected to exhibit fastest growth over the forecast period due to the presence of highly unmet medical needs in the region along with increasing disposable income of the population in the region.
The major players operating in the global cardiac monitoring & cardiac rhythm management market emphasize on product development in order to introduce advanced products in accordance with the changing needs and demands of the market. For instance, in May 2017, Abbott Laboratories announced the CE Mark and first use of its new Confirm Rx Insertable Cardiac Monitor (ICM). It is the world’s first ICM that is compatible with a smartphone which will help physicians in detecting cardiac arrhythmias including atrial fibrillation.
Some of the key players operating in the cardiac monitoring & cardiac rhythm management market are, Abiomed, Berlin Heart GmbH, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Koninklijke Philips N.V., Cardiac Science Corporation, General Electric Company, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc., Schiller AG and St. Jude Medical, LLC.
The key opportunity for the players operating in cardiac monitoring & cardiac rhythm management market lies in the development of technologically advanced products which deliver enhanced value to the patients suffering from cardiovascular diseases. Also, miniaturization of products has been a growing trend in the market which largely improves the convenience of use of cardiac monitoring and rhythm management devices. With increasing disposable income in the emerging markets with prevalence of unmet medical needs, market players can largely benefit by expanding distribution to such markets and secure competitive advantage.
Cardiac Monitoring & Cardiac Rhythm Management Market Segmentation:
Cardiac Monitoring Devices
Electrocardiogram (ECG) Devices
ECG Devices, By Type
ECG Devices, By Lead Type
Cardiac Output Monitoring
Minimally Invasive COM
Implantable Loop Recorder
Event Monitors, By Type
Event Monitors, By Technology
Manual Event Monitors
Cardiac Rhythm Management Devices
Implantable Cardioverter Defibrillators (ICDs)
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
Manual External Defibrillator
Automated External Defibrillator (AEDs)
Semi-automated External Defibrillator
Fully Automated External Defibrillator
Wearable Cardioverter Defibrillator (WCDs)
Cardiac Resynchronization Therapy (CRT) Devices
CRT-P (CRT with Pacemaker Function)
CRT-D (CRT with Pacemaker and ICD Function)
Ventricular Assist Devices (VADs)
Right Ventricular Assist Device (RVAD)
Left Ventricular Assist Device (LVAD)
Biventricular Assist Device (BIVAD)
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
Rest of Europe
Rest of Asia Pacific
Rest of the World
United Arab Emirates
Some of the key questions answered by the report are:
What was the market size in 2016 and forecast from 2017 to 2025?
What will be the industry market growth from 2017 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?